Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)
NCT00365443
·
clinicaltrials.gov ↗
PHASE2
Phase
WITHDRAWN
Status
INDUSTRY
Sponsor class
Conditions
Cervical Cancer
Condylomata Acuminata
Interventions
BIOLOGICAL:
V502
Sponsor
Merck Sharp & Dohme LLC